Kardiovaskuläre Risikofaktoren und deren Bedeutung für die Entstehung der koronaren Herzkrankheit bei der Frau

  • Elisabeth von der Lohe


Die Prävalenz der koronaren Herzkrankheit (KHK) ist unabhängig vom Geschlecht eng mit den folgenden Risikofaktoren verbunden:
  • Alter,

  • genetische Belastung,

  • Rauchen,

  • Hypertonie,

  • Dyslipidä und

  • Diabetes mellitus.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson KM, Wilson PW, Odell PM, Kannel WB (1991) An updated coronary risk profile. Circulation 83:357–363Google Scholar
  2. Austin MA, Shelby JV (1995) LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int J Obes 19(Suppll):S22–26Google Scholar
  3. Barrett-Connor E, Wingard D L (1983) Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 118:489–496PubMedGoogle Scholar
  4. Berlin JA, Colditz GA (1990) A meta-analysis of physical activity in the prevention of coronary he art disease. Am J Epidemiol 132:612–628PubMedGoogle Scholar
  5. Bittner V, Oparil S (1993) Hypertension. In: Douglas PS (ed) Cardiovascular health and disease in women. Saunders, Philadelphia, p 63Google Scholar
  6. Birdsall MA, Farquhar CM, White HD (1997) Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126:32–35PubMedGoogle Scholar
  7. Bostom AG, Gagnon DR, Cuppies A et al. (1994) A prospective investigation of elevated lipoprotein a detectedby electrophoresis and cardiovascular disease in women: The Framingham he art study. Circulation 90:1688PubMedCrossRefGoogle Scholar
  8. Castelli WP, Garrison RJ, Wilson PWF et al. (1986) Incidence of coronary heart disease and lipoprotein cholesterollevels: The Framingham study. JAMA 256:2835–2838PubMedCrossRefGoogle Scholar
  9. Centers of Disease Control (1992) Coronary heart disease incidence by sex - United States. MMWR Morb Mortal Wkly Rep 41(SS-2):526Google Scholar
  10. Coleman MP, Key TJA, Wang EY et al. (1992) A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Artherosclerosis 92:177–185CrossRefGoogle Scholar
  11. Criqui MH, Heiss G, Cohn R et al. (1993) Plasma triglycerides level and mortality from coronary heart disease. N Engl J Med 328:1220–1225PubMedCrossRefGoogle Scholar
  12. Denke MA (1999) Primary prevention of coronary heart disease in postmenopausal women. Am J Med 107 (2 A):48 SCrossRefGoogle Scholar
  13. Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 28:1165–1174CrossRefGoogle Scholar
  14. Eaker ED, Castelli WP (1987) Coronary heart disease and it’s risk factors among women in the Framingham Study. In: Eaker ED, Paker B, Wenger N et al. (eds) Coronary Heart Disease in Women. Haymarket Doyma, New York, p 122Google Scholar
  15. Elveback LR, Connaolly DC, Melton LJ III (1986) Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc 61:896–900PubMedGoogle Scholar
  16. Fried LP, Becker DM (1993) Smoking and cardiovascular disease. In: Douglas PS (ed) Cardiovascular Health and Disease in Women. Saunders, Philadelphia, p 217Google Scholar
  17. Grundy SM, Pasternak R, Greenland P et al. (1999) Assessment of cardiovascular risk by use of multiple risk-factor assessment equations: A statement for healthcare professionals from the American Hear Association and the American College of Cardiology. Circulation 100:1481PubMedCrossRefGoogle Scholar
  18. Hayes SN, Taler SJ (1998) Hypertension in women: current understanding of gen der differences. Mayo Clin Proc 73:157PubMedCrossRefGoogle Scholar
  19. Heyden S, Heiss G, Bartel AG et al. (1980) Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 33:265–273PubMedCrossRefGoogle Scholar
  20. Hermanson B, Omenn GS, Kronmal RA et al. (1988) Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: Results from CASS registry. N Engl J Med 319:1365PubMedCrossRefGoogle Scholar
  21. Howard BV, Lee ET, Cowan LD et al. (1995) Coronary he art disease prevalence and its relation to risk factors in American Indians: The Strong Heart Study. Am J Epidemiol 142:254–268PubMedGoogle Scholar
  22. Howard BV, Cowan LD, Haffner SM (1997) Women, Diabetes, Lipoproteins, and the Risk for Coronary Heart Disease. In: Forte TM (ed) Hormonal, metabolie, and cellular influences on cardiovascular disease in women. Futura Publishing Company, Armonk/NY, S 262Google Scholar
  23. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P (1999) Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14.786 middle-aged men and women in Finland. Circulation 99:1165PubMedCrossRefGoogle Scholar
  24. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: The Framingham study. JAMA 241:2035–2038PubMedCrossRefGoogle Scholar
  25. Kannel WB, Wilson PWF (1995) Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57PubMedCrossRefGoogle Scholar
  26. Kaplan NM (1989) The deadly quartet: upper-body obesity, glucose intolerance, hypertryglyceridemia, and hypertension. Arch Intern Med 149:1514PubMedCrossRefGoogle Scholar
  27. Kushi LH, Fee RM, Folsom AR et al. (1997) Physical activity and mortality in postmenopausal women. JAMA 277:1287PubMedCrossRefGoogle Scholar
  28. LaRosa JC (1993) Lipoproteins and lipid disorders. In: Douglas PS (ed) Cardiovascular health and disease in women. Saunders, Philadelphia, p 175Google Scholar
  29. LaRosa JC (1997) Triglycerides and coronary risk in women and the elderly. Arch Intern Med 157:961PubMedCrossRefGoogle Scholar
  30. Laws A, King AC, Haskell WL, Reaven GM (1993) Metabolie and behavioral covariates of high-density lipoprotein cholesterol and triglycerides concentrations in post-menopausal women. J Am Geriatr Soc 41:l289–1294Google Scholar
  31. Lemaitre RN, Heckbert SR, Psaty BM et al. (1995) Leisure-time physical activity and the risk of nonfatal myocardial infarction in postmenopausal women. Arch Intern Med 155:2302PubMedCrossRefGoogle Scholar
  32. Manson JE, Colditz GA, Stampfer MJ et al. (1991) A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.Arch Intern Med 151:1141–1147PubMedCrossRefGoogle Scholar
  33. Manson JE, Hu FB, Rich-Edwards JW et al. (1999) A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 341:650PubMedCrossRefGoogle Scholar
  34. Miller VT (1994) Lipids, lipoproteins women and cardiovascular disease. Artherosclerosis 108:S73CrossRefGoogle Scholar
  35. Mosca L, Grundy SM, Judelson D et al. (1999) Guide to preventative cardiology for women. Circulation 99:2480PubMedCrossRefGoogle Scholar
  36. Mosca L, Manson JE, Sutherland SE et al. (1997) Cardiovascular disease in women: A statement for healthcare professionals from the AHA. Circulation 96:2468PubMedCrossRefGoogle Scholar
  37. National Cholesterol Education Program (1994) Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 89:1329–1445Google Scholar
  38. Ridker PM, Buring JE, Shih J et al. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733PubMedCrossRefGoogle Scholar
  39. Ridker PM, Rifai N, Pfeffer MA et al. (1999) Long-term effects of Pravastatin on plasma concentration of C-reactive protein. Circulation 100:230–235PubMedCrossRefGoogle Scholar
  40. Ridker PM, Hennekens CH, Buring JE et al. (2000) C-reactive protein and other markers of inflammation in tlIe prediction of cardiovascular disease in women. N Engl J Med 342:836–843PubMedCrossRefGoogle Scholar
  41. Rimm EB, Willett WC, Hu FB et al. (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279:359–364PubMedCrossRefGoogle Scholar
  42. Robinson S, Henderson AD, Gelding SV et al. (1996) Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 44:277–284CrossRefGoogle Scholar
  43. Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S (1985) Myocardial infarcation and cigarette smoking in women younger than 50 years of age. JAMA 253(20): 2965–2969PubMedCrossRefGoogle Scholar
  44. Second Joint Task Force of European and other societies on Coronary Prevention (1998) Prevention of coronary heart disease in clinical practice. Eur Heart J 19:1434–1503CrossRefGoogle Scholar
  45. Shapiro S, Sloane D, Rosenberg L et al. (1979) Oral contraceptive use in relation to myocardial infarction. Lancet 1:743PubMedCrossRefGoogle Scholar
  46. Shlipak MG, Simon JA, Vittinghoff E et al. (2000) Estrogen and progestin, lipoprtein (a), and the risk of recurrent coronary heart disease events after menopause. JAMA 283:1845–1852PubMedCrossRefGoogle Scholar
  47. Stampfer MJ, Malinow MR, Willett WC (1998) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in U. S. physicians. JAMA 279:359–364PubMedCrossRefGoogle Scholar
  48. Talbott E, Guzick D, Clerici A et al. (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Aterioscler Thromb Va sc Biol 15:821–826CrossRefGoogle Scholar
  49. Van Poppel G, Kardinaal A, Princen H, Kok FJ (1994) Antioxidants and coronary heart disease. Ann Med 26:429–434PubMedCrossRefGoogle Scholar
  50. Walsh JME (1999) Lipids. In: Charney P (ed) Coronary artery disease in women: What all physicians need to know.American College of Physician Press, Philadelphia, p 1041Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Elisabeth von der Lohe
    • 1
  1. 1.Wishard Health ServicesKrannert Institute of CardiologyIndianapolisUSA

Personalised recommendations